Loading...
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
JAZZ
JAZZ News & Events
-
Add to Watchlist
Trade JAZZ
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Forecast
Technical
Valuation
Financials
Earnings
Should I Buy
News
JAZZ News
Harmony Biosciences: Financial Success Amidst Challenges
2 days ago
Fool
Harmony's Wakix Drug: Financial Success Amid Controversy
2 days ago
NASDAQ.COM
Zymeworks (ZYME) 2026 Milestones Expected to Drive Long-Term Value with Promising ZW191 Data
Jan 12 2026
NASDAQ.COM
Jazz Pharmaceuticals Appoints Thomas Riga as Chief Business Officer to Drive Strategic Development
Jan 08 2026
PRnewswire
Jazz Pharmaceuticals Appoints Thomas Riga as Chief Business Officer to Drive Strategic Development
Jan 08 2026
Newsfilter
Jazz Pharmaceuticals Reports Ziihera Trial Shows Significant Survival Benefits
Jan 07 2026
Benzinga
Jazz Pharmaceuticals Reports Positive HERIZON-GEA-01 Trial Results for Ziihera in Cancer Treatment
Jan 07 2026
NASDAQ.COM
Jazz Pharmaceuticals' Ziihera Therapy Significantly Improves Survival in HER2+ Gastric Cancer
Jan 06 2026
Newsfilter
Show More News
JAZZ Events
No data
JAZZ Monitor News
Jazz Pharmaceuticals Appoints Thomas Riga as Chief Business Officer
Jan 14 2026
Jazz Pharmaceuticals faces stock decline amid market weakness
Jan 08 2026
Jazz Pharmaceuticals falls amid sector rotation despite market gains
Jan 06 2026
JAZZ.O Hits 52-Week High on Positive Trial Results
Nov 18 2025
JAZZ.O Hits 52-Week High on Positive Trial Results
Nov 17 2025
JAZZ Earnings Analysis
Jazz Pharmaceuticals Hits Record Q3 Revenue- Intellectia AI™
2 months ago
Jazz Pharma Reports Record-Breaking 2024 Earnings- Intellectia AI™
11 months ago
People Also Watch
